Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

ETR/2HQ stock hub

ETR/2HQ has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ETR/2HQis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

563.5M

Deutsche Börse Xetra

Market data

Live price

Current market quote for this ticker.

Current price

ETR/2HQ

In the news

Latest news · ETR/2HQ

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E11

P25 12.3P50 15.7P75 20.2

Trailing P/En/a

P25 16.4P50 20.9P75 30.4

ROE-63.2

P25 -6.7P50 8.5P75 17.2

ROIC-4

P25 -1.7P50 8.5P75 17.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ETR/2HQ market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

182

Groups with data

Currency

USD

Showing 182 of 182 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	2,842
Employees Change	192%
Employees Change Percent	7.25
Enterprise value	EUR 619M
Exchange	Deutsche Börse Xetra
Financial currency	USD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	US88688T1007
Last refreshed	2026-05-10
Market cap	EUR 563.5M
Price	EUR 0.68
Price currency	EUR
Rev Per Employee	255,579.92x
Sector	Healthcare
Sic	2834
Symbol	etr/2HQ
Website	https://www.tilray.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-201.96%
EV Earnings	-0.54x
EV/EBITDA	34.64x
EV/FCF	-9.91x
EV/Sales	0.85x
FCF yield	-11.08%
Forward P/E	10.96x
P/B ratio	0.44x
P/S ratio	0.78x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-7.52%
EBITDA Margin	2.07%
Gross margin	27.68%
Gross Profit	EUR 201M
Gross Profit Growth	-7.59%
Gross Profit Growth Q	5.54%
Gross Profit Growth3 Y	44.64%
Gross Profit Growth5 Y	23.44%
Net Income	EUR -1.1B
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Pretax Margin	-169.76%
Profit Margin	-156.67%
Profit Per Employee	EUR -400,405
ROA	-1.47
Roa5y	-1.87
ROCE	-3.55
ROE	-63.16
Roe5y	-30.72
ROIC	-4.04
Roic5y	-3.64

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-94.76%
Cagr3y	-73.36%
EPS Growth Quarters	2
EPS Growth Years	0
Revenue Growth	3.83x
Revenue Growth Q	11.28x
Revenue Growth Quarters	2x
Revenue Growth Years	2x
Revenue Growth3 Y	12.91x
Revenue Growth5 Y	12.89x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.31
Assets	EUR 1.8B
Cash	EUR 186.1M
Current Assets	EUR 609.5M
Current Liabilities	EUR 218.4M
Debt	EUR 268.3M
Debt EBITDA	EUR 15.07
Debt Equity	EUR 0.21
Debt FCF	EUR -4.3
Equity	EUR 1.3B
Interest Coverage	-1.99
Liabilities	EUR 464.7M
Long Term Assets	EUR 1.1B
Long Term Liabilities	EUR 246.3M
Net Cash	EUR -82.2M
Net Cash By Market Cap	EUR -14.59
Net Debt EBITDA	EUR 5.47
Net Debt Equity	EUR 0.06
Tangible Book Value	EUR 661.5M
Tangible Book Value Per Share	EUR 5.69
WACC	13.36

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.79
Inventory Turnover	2.23
Net Working Capital	EUR 232.6M
Quick ratio	1.31
Working Capital	EUR 390.3M
Working Capital Turnover	EUR 1.64

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-26.41%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-94.74%
200-day SMA	7.38
3Y total return	-98.11%
50-day SMA	11.57
50-day SMA vs 200-day SMA	50over200
All Time High	186.1
All Time High Change	-99.63%
All Time High Date	2021-06-09
All Time Low	0.66
All Time Low Change	3.47%
All Time Low Date	2025-12-01
ATR	0.84
Beta	2.12
Ch YTD	-95.02
High	0.71
High52	19.88
High52 Date	2025-10-09
High52ch	-96.58%
Low	0.66
Low52	0.66
Low52 Date	2025-12-01
Low52ch	3.47%
Ma50ch	-94.12%
Price vs 200-day SMA	-90.78%
RSI	28
RSI Monthly	37.92
RSI Weekly	42.02
Sharpe ratio	-0.08x
Sortino ratio	-0.07
Total Return	-26.41%
Tr YTD	-95.02
Tr1m	-94.08%
Tr1w	-91.85%
Tr3m	-94.3%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -54.7M
Operating margin	-7.52

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	118,367,051%
Net Borrowing	-13,456,309
Shares Insiders	0.77%
Shares Institutions	7.54%
Shares Qo Q	2.11%
Shares Yo Y	26.41%
Short Ratio	3.28

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -93.9M
Average Volume	16,047.75x
Bv Per Share	11.34
CAPEX	EUR -24.7M
Ch1m	-94.08
Ch1w	-91.85
Ch1y	-94.74
Ch3m	-94.3
Ch3y	-98.11
Ch6m	-82.78
Change	-5.05%
Change From Open	-2.75
Close	0.72
Days Gap	-2.37
Depreciation Amortization	69,821,191.1
Dollar Volume	83,530.5
Earnings Date	2026-07-24
EBIT	EUR -54.7M
EBITDA	EUR 15M
EPS	EUR -10.68
F Score	4
FCF	EUR -62.5M
FCF EV Yield	-10.09x
Financing CF	67,248,691
Fiscal Year End	May
Goodwill	637,964,210.7
Income Tax	EUR -103.2M
Investing CF	7,532,070
Is Primary Listing	0
Last Earnings Date	2026-04-01
Last Report Date	2026-02-28
Ma150	7.96
Ma150ch	-91.46%
Ma20	9.25
Ma20ch	-92.65%
Net CF	41,933,319
Next Earnings Date	2026-07-24
Open	0.7
Position In Range	42.7
Ppne	475,661,740
Price Date	2025-12-01
Price EBITDA	EUR 37.49
Ptbv Ratio	0.85
Relative Volume	7.65x
Revenue	726,358,133x
SBC By Revenue	4.33x
Share Based Comp	31,448,508
Tax By Revenue	-14.2x
Tr6m	-82.78%
Volume	122,839
Z Score	-1.72

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ETR/2HQ pay a dividend?

Capital-return profile for this ticker.

Performance

ETR/2HQ stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ETR/2HQ?

Insider, institutional, and short-interest positioning.

Institutional ownership

+7.5%

Share of float held by funds and institutions

Insider ownership

+0.8%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

ETR/2HQ momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

28.0

Below 30: short-term oversold

Price vs 200-day MA

-90.8%

50/200-day relationship not available

Beta (5Y)

2.12

More volatile than the market

Sharpe ratio

-0.08

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ETR/2HQ

Hub-level FAQ points readers to the deeper analysis pages.

What is the current etr/2HQ stock rating?

etr/2HQ is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full etr/2HQ analysis?

The full report lives at /stocks/etr/2HQ/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for etr/2HQ?

The latest report frames etr/2HQ around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the etr/2HQ page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.